A year on, Intel's touted AI-chip deals have fallen short

Full Article
A year on, Intel's touted AI-chip deals have fallen short

Intel has abandoned its forecast of over $500 million in sales for its Gaudi AI accelerator chips in 2024, citing slower uptake due to software issues and a transition to a new chip generation. Despite a positive revenue forecast that temporarily boosted its stock, Intel's shares remain significantly down for the year as it grapples with competition from Nvidia. The company's challenges highlight ongoing difficulties in establishing a competitive AI strategy.

CEO Pat Gelsinger's earlier optimism about Intel's AI prospects has been tempered by disappointing sales figures and questions from analysts regarding the company's AI strategy. While Intel reported third-quarter revenues exceeding estimates, it also faced a substantial loss, raising concerns about its operational control and market position. The situation underscores the need for Intel to solidify its AI offerings to compete effectively in a rapidly evolving market.

• Intel scrapped its $500 million Gaudi chip sales forecast for 2024.

• Analysts question Intel's competitive position in the AI market.

Key AI Terms Mentioned in this Article

AI Accelerator Chips

Gaudi chips are designed to enhance the performance of AI applications but have not met sales expectations.

AI Strategy

Intel's AI strategy is under scrutiny as it struggles to compete with Nvidia's offerings.

Data Centers

CPUs are increasingly important in data centers for AI applications, reflecting market demand.

Companies Mentioned in this Article

Intel

Intel is a major player in the semiconductor industry, focusing on AI chip development.

Nvidia

Nvidia is a leading competitor in AI hardware, particularly known for its GPUs used in AI applications.

TSMC

TSMC is a contract chipmaker that supplies components critical to Intel's production capabilities.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics